3D HI and SHI of UCA
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Breast Cancer
Conditions
Breast Cancer
Trial Timeline
Nov 1, 2011 → Apr 5, 2019
NCT ID
NCT01490892About 3D HI and SHI of UCA
3D HI and SHI of UCA is a approved stage product being developed by Lantheus Holdings for Breast Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01490892. Target conditions include Breast Cancer.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01490892 | Approved | Completed |
Competing Products
20 competing products in Breast Cancer